Skip to content

Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Toric Contact Lenses

Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Toric Contact Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05959200
Enrollment
92
Registered
2023-07-25
Start date
2023-08-14
Completion date
2023-10-23
Last updated
2024-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ametropia, Myopia, Hyperopia, Astigmatism

Brief summary

The primary objective of this study is to evaluate the axis orientation of LID226397 toric contact lenses.

Detailed description

Subjects will be expected to attend 7 visits including a screening visit. The total duration of a subject's participation in the study will be approximately 40 days.

Interventions

DEVICESerafilcon A toric contact lenses

Silicone hydrogel contact lenses for the optical correction of refractive ametropia (myopia or hyperopia with astigmatism)

DEVICESenofilcon A toric contact lenses

Silicone hydrogel contact lenses for the optical correction of refractive ametropia (myopia or hyperopia with astigmatism)

Hydrogen peroxide-based contact lens cleaning and disinfecting solution

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Key Inclusion Criteria: * Successful wearers of any commercial soft toric contact lenses (except AOfAHP and daily disposable lenses) in both eyes with at least 3 months wearing experience, with a minimum wearing time of 5 days per week and 10 hours per day. * Able to be fit with and wear contact lenses within the available range of sphere & cylinder power and axes. * Best corrected distance visual acuity greater than or equal to 20/25 Snellen (0.10 logMAR) in each eye as determined by manifest refraction at screening. * Other protocol-defined inclusion criteria may apply. Key

Exclusion criteria

* Wearing habitual contact lenses in an extended wear modality (routinely sleeping in lenses for at least 1 night per week) over the last 3 months prior to enrollment. * Habitual AOfAHP contact lens wearers and habitual daily disposable lens wearers (worn within last 3 months). * Other

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Lenses With Axis Orientation Within Plus or Minus 30 Degrees From the Intended Axis at 10 Minutes After Lens InsertionDay 1 Dispense, 10 minutes after lens insertion, for each wear period. Each wear period is approximately 14 days according to randomization assignment.The investigator will view the contact lens through a slit lamp (biomicroscope) and record the axis orientation (-179° to +180°) as the number of degrees away from the ideal location (90° axis) either positive or negative depending on the direction (nasal \[+\] or temporal \[-\]). No hypothesis testing was prespecified for this endpoint.

Countries

United States

Participant flow

Recruitment details

Participants were recruited from 7 investigative sites located in 1 country (US).

Pre-assignment details

This reporting group includes all participants exposed to any study lenses evaluated in this study.

Participants by arm

ArmCount
LID226397, Then AOfAHP
Serafilcon A toric contact lenses worn in Period 1, with senofilcon A toric contact lenses worn in Period 2. Each product was worn bilaterally (in both eyes) during waking hours for approximately 14 days. CLEAR CARE was used for nightly contact lens cleaning and disinfection.
48
AOfAHP, Then LID226397
Senofilcon A toric contact lenses worn in Period 1, with serafilcon A toric contact lenses worn in Period 2. Each product was worn bilaterally (in both eyes) during waking hours for approximately 14 days. CLEAR CARE was used for nightly contact lens cleaning and disinfection.
44
Total92

Baseline characteristics

CharacteristicAOfAHP, Then LID226397TotalLID226397, Then AOfAHP
Age, Continuous32.0 years
STANDARD_DEVIATION 9.6
32.3 years
STANDARD_DEVIATION 9.6
32.7 years
STANDARD_DEVIATION 9.7
Race/Ethnicity, Customized
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Asian
10 Participants21 Participants11 Participants
Race/Ethnicity, Customized
Black or African American
3 Participants5 Participants2 Participants
Race/Ethnicity, Customized
Hispanic or Latino
10 Participants15 Participants5 Participants
Race/Ethnicity, Customized
Multi-racial
1 Participants1 Participants0 Participants
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race/Ethnicity, Customized
Not Hispanic or Latino
33 Participants76 Participants43 Participants
Race/Ethnicity, Customized
Not Reported
1 Participants1 Participants0 Participants
Race/Ethnicity, Customized
Other
1 Participants1 Participants0 Participants
Race/Ethnicity, Customized
White
29 Participants64 Participants35 Participants
Sex: Female, Male
Female
33 Participants55 Participants22 Participants
Sex: Female, Male
Male
11 Participants37 Participants26 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 1840 / 920 / 1840 / 92
other
Total, other adverse events
0 / 1840 / 920 / 1840 / 92
serious
Total, serious adverse events
0 / 1840 / 920 / 1840 / 92

Outcome results

Primary

Percentage of Lenses With Axis Orientation Within Plus or Minus 30 Degrees From the Intended Axis at 10 Minutes After Lens Insertion

The investigator will view the contact lens through a slit lamp (biomicroscope) and record the axis orientation (-179° to +180°) as the number of degrees away from the ideal location (90° axis) either positive or negative depending on the direction (nasal \[+\] or temporal \[-\]). No hypothesis testing was prespecified for this endpoint.

Time frame: Day 1 Dispense, 10 minutes after lens insertion, for each wear period. Each wear period is approximately 14 days according to randomization assignment.

Population: Full Analysis Set: All randomized subjects/eyes exposed to any study lenses evaluated in this study.

ArmMeasureValue (NUMBER)
LID226397Percentage of Lenses With Axis Orientation Within Plus or Minus 30 Degrees From the Intended Axis at 10 Minutes After Lens Insertion100.0 percentage of lenses
AOfAHPPercentage of Lenses With Axis Orientation Within Plus or Minus 30 Degrees From the Intended Axis at 10 Minutes After Lens Insertion100.0 percentage of lenses

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026